Stock Region Research
Subscribe
Sign in
Share this discussion
Biopharmaceutical Company Announces First Patient Dosed In Cancer Treatment Trial
stockregion.app
Copy link
Facebook
Email
Note
Other
Biopharmaceutical Company Announces First…
Stock Region
Jul 15
Share this post
Biopharmaceutical Company Announces First Patient Dosed In Cancer Treatment Trial
stockregion.app
Copy link
Facebook
Email
Note
Other
Verastem Oncology Announces First Patient Dosed in Phase 1/2 Trial of GFH375/VS-7375 in China.
Read →
0 Comments
Share
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Biopharmaceutical Company Announces First Patient Dosed In Cancer Treatment Trial
Biopharmaceutical Company Announces First…
Biopharmaceutical Company Announces First Patient Dosed In Cancer Treatment Trial
Verastem Oncology Announces First Patient Dosed in Phase 1/2 Trial of GFH375/VS-7375 in China.